IMR Press / JIN / Special Issues / neuromyelltis_optica_spectrum_disorder

Research Advances in Neuromyelitis Optica Spectrum Disorder

Submission deadline: 30 July 2023
Special Issue Editor
  • Victor M. Rivera, MD
    Baylor College of Medicine, Houston, TX, USA
    Interests: demyelinating diseases
Special Issue Information

Dear Colleagues,

It gives me great pleasure to invite you to contribute to the Special Issue “Advances in Neuromyelitis Optica Spectrum Disorder (NMOSD)” for the Journal of Integrative Neurosciences.

NMOSD is a major inflammatory demyelinating disorder of the CNS with a complex autoimmune etiology that has yet to be fully understood. This disorder has multifocal clinical manifestations and despite its reportedly low frequency, has become a topic of great international interest. Major challenges remain in the diagnosis and management of NMOSD, and its prevalence in non-white Caucasian populations is the opposite to that of Multiple Sclerosis (MS). The discovery in NMOSD patients of serum IgG class antibodies that bind to the water channel aquaporin-4 (AQP4-IgG) suggest this disorder is a different entity to MS. NMOSD is a serious neurological disease that co-occurs with other autoimmune syndromes, thus carrying a high degree of clinical morbidity and sometimes even a fatal outcome. Three evidence-based medications have been approved by international health agencies and these disease-modifying agents are gradually being incorporated into therapeutic schemes. However, the management of this disease is still an unmet need and remains an international concern.

Your contribution to this special issue will enhance and disseminate knowledge of different aspects of NMOSD, including basic research, epidemiology, clinical aspects, diagnosis including neuroimaging, and treatment. Our projected deadline for submissions is July 30, 2023.

Wishing you the best in your professional endeavors.

Sincerely,
Dr. Victor M. Rivera
Guest Editor

Keywords
Neuromyelltis Optica Spectrum Disorder
AQP-4 IgG antibody
NMO epidemiology
neuroimagen
NMO therapy
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (3 Papers)
Back to top